BioAtla Inc (BCAB)

NASDAQ

$3.70

BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers. The company is headquartered in San Diego, California.

Website: https://www.bioatla.com

Sector:

Healthcare

Industry:

Biotechnology

Target: $10 (+170.27%)

Market Cap

$7.07M

Beta (5Y)

1.34

Price Chart

Adjust inflation

Log

Valuation

Market Cap$7.07M

P/S3.54

P/B2.68

Profitability

Gross Profit (TTM)-$33M

EBITDA-$51M

Operating Margin-2495%

EPS-$40.88

Growth & Risk

FCF 5Y CAGR-4.79%

Beta (5Y)1.34

Sharpe Ratio-0.53